Literature DB >> 18620768

Field observations during the Bluetongue serotype 8 epidemic in 2006. II. Morbidity and mortality rate, case fatality and clinical recovery in sheep and cattle in the Netherlands.

Armin R W Elbers1, Anoek Backx, Koen Mintiens, Guillaume Gerbier, Christoph Staubach, Guy Hendrickx, Arco van der Spek.   

Abstract

Data collected in the Netherlands during the Bluetongue serotype 8 (BTV-8) epidemic indicated that in outbreak cattle herds, predominantly dairy and nursing cows were clinically affected and not young stock, beef cattle, beef calves, or breeding animals. In outbreak sheep flocks, mainly ewes and--if present--rams, were clinically affected and not the lambs. Median morbidity rate in outbreak herds was 1.85 per 100 sheep-month at risk and 0.32 per 100 cattle-month at risk for sheep and cattle, respectively. The mean proportion of BT-affected animals in outbreak herds that recovered from clinical disease was approximately eight times higher for cattle compared to sheep in the Netherlands. Median mortality rate in outbreak herds was 0.5 per 100 sheep-month at risk of dying and 0 per 100 cattle-month at risk of dying for sheep and cattle, respectively. Median recovery time of both sheep and cattle that recovered from clinical disease in outbreak herds was 14 days. Median case fatality was 50% in sheep outbreak flocks and 0% in outbreak cattle herds. It is concluded that morbidity and mortality in outbreak cattle herds was very limited during the BTV-8 epidemic in the Netherlands in 2006. In outbreak sheep flocks, morbidity was limited, with exceptions for a few flocks. However, almost 50% of the clinically sick sheep died in outbreak sheep herds.

Entities:  

Mesh:

Year:  2008        PMID: 18620768     DOI: 10.1016/j.prevetmed.2008.06.003

Source DB:  PubMed          Journal:  Prev Vet Med        ISSN: 0167-5877            Impact factor:   2.670


  35 in total

Review 1.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

2.  The first report on serotyping of bluetongue virus in small ruminants of Khyber Pakhtunkhwa province, Pakistan.

Authors:  Amir Iftikhar Malik; Muhammad Ijaz; Tahir Yaqub; Muhammad Zubair Shabir; Muhammad Avais; Awais Ghaffar; Ahmad Ali; Shahid Hussain Farooqi; Khalid Mehmood
Journal:  Trop Anim Health Prod       Date:  2018-11-07       Impact factor: 1.559

3.  Meeting report VLPNPV: Session 5: Plant based technology.

Authors:  Lydia R Meador; Tsafrir S Mor
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Activation of TLR3/interferon signaling pathway by bluetongue virus results in HIV inhibition in macrophages.

Authors:  Ming Dai; Xu Wang; Jie-Liang Li; Yu Zhou; Ming Sang; Jin-Biao Liu; Jian-Guo Wu; Wen-Zhe Ho
Journal:  FASEB J       Date:  2015-08-21       Impact factor: 5.191

5.  Characteristics of Wind-Infective Farms of the 2006 Bluetongue Serotype 8 Epidemic in Northern Europe.

Authors:  Luigi Sedda; David Morley; Heidi E Brown
Journal:  Ecohealth       Date:  2015-01-01       Impact factor: 3.184

6.  The spread of bluetongue virus serotype 8 in Great Britain and its control by vaccination.

Authors:  Camille Szmaragd; Anthony J Wilson; Simon Carpenter; James L N Wood; Philip S Mellor; Simon Gubbins
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

7.  Epidemiological characteristics and clinicopathological features of bluetongue in sheep and cattle, during the 2014 BTV serotype 4 incursion in Greece.

Authors:  Panagiotis-Dimitrios Katsoulos; Nektarios D Giadinis; Serafeim C Chaintoutis; Chrysostomos I Dovas; Evangelos Kiossis; Georgios Tsousis; Vassilios Psychas; Ioannis Vlemmas; Theologos Papadopoulos; Orestis Papadopoulos; Stéphan Zientara; Harilaos Karatzias; Constantinos Boscos
Journal:  Trop Anim Health Prod       Date:  2016-01-14       Impact factor: 1.559

8.  Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.

Authors:  Eiko Matsuo; Cristina C P Celma; Mark Boyce; Cyril Viarouge; Corinne Sailleau; Eric Dubois; Emmanuel Bréard; Richard Thiéry; Stéphan Zientara; Polly Roy
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

9.  Comparison of pre-emptive and reactive strategies to control an incursion of bluetongue virus serotype 1 to Great Britain by vaccination.

Authors:  T Sumner; L Burgin; J Gloster; S Gubbins
Journal:  Epidemiol Infect       Date:  2012-04-04       Impact factor: 4.434

10.  A modeling framework to describe the transmission of bluetongue virus within and between farms in Great Britain.

Authors:  Camille Szmaragd; Anthony J Wilson; Simon Carpenter; James L N Wood; Philip S Mellor; Simon Gubbins
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.